Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-430814

  • Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2017 – 2023

  • Publish: June 2016 | Report Code: HBI-430814

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Global Vaccines Market, growing importance of communicable diseases and new threats, significant unmet needs, cost effectiveness of immunizations, new markets will continue to drive over the coming years. Vaccines are considered to be among the most significant healthcare advances that have helped save countless lives by providing immunization against deadly diseases. The global vaccination market comprises a wide range of vaccines to prevent diseases in adults, adolescents and children. The growth of the global vaccination market is being led by higher demand from the increasing population in the emerging countries, coupled with advances in immunology, genetics and vaccine technology.

Enlarging target population and larger emerging markets remain opportunity pockets

Vaccine technology is set to witness a revolution, as a deeper understanding of the human immune system's protective antibody and cell-based responses to foreign antigens will lead to the development of innovative diagnostics and advancement of therapeutic applications. As more governments across the world recognize the benefits of mass vaccination, the trend of vaccines delivering healthcare solutions on a large scale will continue. Given the increasing demand worldwide and currently-unmet needs, the global vaccination market has significant potential for technological innovation and revenue growth.
 
Vaccines are an unmatched tool for efficient healthcare management due to their low cost and extended protection. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccines; recently developed vaccines that are safer and more effective; better public awareness; technological advancements in molecular genetics domain; and the adoption of novel vaccine delivery mechanisms are primarily driving the growth of the global vaccination market. Moreover, the development of new therapeutic and prophylactic vaccines for combating HIV/AIDS, congenital abnormalities, malaria, SARS and cancer, as well as other fatal diseases is also contributing the market's growth. The growing importance of communicable diseases and new threats, significant unmet needs, cost effectiveness of immunizations, new markets will continue to drive the of the global vaccination market over the coming years.
 
1.    INTRODUCTION
1.1.    EXECUTIVE SUMMARY
1.2.    ESTIMATION METHODOLOGY
 
2.     MARKET OVERVIEW
2.1.    MARKET DEFINITION AND SCOPE
2.2.    KEY FINDINGS
2.3.       PARAMETRIC TECHNOLOGIES
2.3.1.    RAW MATERIAL SUPPLIER
2.3.2.    PRODUCTION GEOGRAPHICALLY
2.3.3.     ADOPTION ACROSS VARIOUS INDUSTRIES
2.4.     KEY MARKET INSIGHTS
2.4.1.    TOP 3 EMERGING COUNTRIES
2.4.2.    TOP 3 REVENUE GENERATING SEGMENTS
2.4.3.    TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4.     TOP 3 GEOGRAPHY
2.5.     COMPETITIVE LANDSCAPE
2.5.1.     MARKET SHARE TECHNOLOGIES
2.5.2.    TOP WINNING STRATEGIES
2.5.3.    CASE STUDIES: TOP COMPETITIVE MOVES
2.6.    PORTER’S FIVE FORCE MODEL
2.6.1.    THREAT OF NEW ENTRANTS
2.6.2.    THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3.     BARGAINING POWER OF BUYER
2.6.4.     BARGAINING POWER OF SUPPLIER
2.6.5.     INTENSITY OF COMPETITIVE RIVALRY
2.7.      KEY BUYING CRITERIA
2.8.    STRATEGIC RECOMMENDATION
2.9.     STRATEGIC CONCLUSIONS
 
3.    MARKET DETERMINANTS
3.1.    MARKET DRIVERS
3.1.1.    RISING USE OF ADJUVANTS IN VACCINE-PREVENTABLE DISEASES
3.1.2.    INCREASING GOVERNMENT INVESTMENTS AND INITIATIVES.  
3.1.3.    RISING COMPANY INVESTMENTS IN VACCINE DEVELOPMENT
3.1.4.    INCREASING INITIATIVES BY NON-GOVERNMENT ORGANIZATIONS
3.2.    MARKET RESTRAINTS
3.2.1.    RISING COST OF RESEARCH  
3.2.2.    HIGH REGULATORY HURDLES
3.3.    MARKET OPPORTUNITIES
3.3.1.    COMBINED ADJUVANTS
3.3.2.    VACCINES FOR YOUNG CHILDREN
3.3.3.    WIDESPREAD OF DISEASES
3.3.4.    INCREASING DEMAND IN EMERGING ECONOMIES
3.4.    MARKET CHALLENGES    
3.4.1.    RECOGNITION OF ADJUVANTS
3.5.    PARENT MARKET
3.6.    COMPETITORS MARKET
3.7.     ALTERNATIVE MARKET
4.    MARKET SEGMENTATION
4.1.    BY TECHNOLOGY
4.1.1.    GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES 2014-2023 ($ MILLION)
4.1.2.    GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES 2014-2023 ($ MILLION)
4.1.3.    GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES 2014-2023 ($ MILLION)
4.1.4.    GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES 2014-2023 ($ MILLION)
4.1.5.    GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES 2014-2023 ($ MILLION)
4.1.6.    GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES 2014-2023 ($ MILLION)
4.1.7.    GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES 2014-2023 ($ MILLION)
4.1.8.    GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES 2014-2023 ($ MILLION)
4.2.    BY TYPE
4.2.1.    GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES 2014-2023 ($ MILLION)
4.2.2.    GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES 2014-2023 ($ MILLION)
4.3.    BY DISEASE INDICATION
4.3.1.    GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES 2014-2023 ($ MILLION)
4.3.1.1.    GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA
4.3.1.2.    GLOBAL VACCINES & VACCINATION MARKET BY MMR 2014-2023 ($ MILLION)
4.3.1.3.    GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA 2014-2023 ($ MILLION)
4.3.1.4.    GLOBAL VACCINES & VACCINATION MARKET BY DTP 2014-2023 ($ MILLION)
4.3.1.5.    GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS 2014-2023 ($ MILLION)
4.3.1.6.    GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS 2014-2023 ($ MILLION)
4.3.1.7.    GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA 2014-2023 ($ MILLION)
4.3.1.8.    GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL 2014-2023 ($ MILLION)
4.3.1.9.    GLOBAL VACCINES & VACCINATION MARKET BY POLIO 2014-2023 ($ MILLION)
4.3.1.10.    GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2023 ($ MILLION)
4.3.2.    GLOBAL VACCINES & VACCINATION MARKET BY CANCER 2014-2023 ($ MILLION)
4.3.2.1.    GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER  2014-2023 ($ MILLION)
4.3.2.2.    GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2023 ($ MILLION)
4.3.3.    GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES 2014-2023 ($ MILLION)
4.4.    BY END USERS
4.4.1.    GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS 2014-2023 ($ MILLION)
4.4.2.    GLOBAL VACCINES & VACCINATION MARKET BY ADULTS 2014-2023 ($ MILLION)
 
5.    GEOGRAPHICAL TECHNOLOGIES
5.1.    NORTH AMERICA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.1.1.    UNITED STATES (U.S.) VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.1.2.    CANADA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.2.    EUROPE VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.2.1.    UNITED KINGDOM (UK) VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.2.2.    FRANCE VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.2.3.    GERMANY VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.2.4.    SPAIN VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.2.5.    ITALY VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.2.6.     ROE VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.3.     ASIA PACIFIC VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.3.1.    INDIA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.3.2.    CHINA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.3.3.     JAPAN VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.3.4.     KOREA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.3.5.     AUSTRALIA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.3.6.    ROAPAC VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.4.      REST OF THE WORLD VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.4.1.      LATIN AMERICA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.4.2.     MENA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
5.4.3.     AFRICA VACCINES & VACCINATION MARKET 2014-2023 ($ MILLION)
 
6.    COMPANY PROFILES
1.    ABBOTT
2.    ASTRAZENECA
3.    BAVARIAN NORDIC
4.    BAXTER
5.    BHARAT BIOTECH
6.    BIO MED
7.    CSL LIMITED
8.    EMERGENT BIOSOLUTIONS, INC.
9.    GLAXOSMITHKLINE, PLC
10.    JOHNSON &JOHNSON
11.    MEDIMMUNE, LLC. (A SUBSIDIARY OF ASTRAZENECA)
12.    MERCK &CO., INC.
13.    NOVARTIS AG
14.    PFIZER, INC.
15.    SANOFI
LIST OF TABLE
1.    GLOBAL VACCINES & VACCINATION MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
2.    GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES 2014-2023 ($ MILLION)
3.    GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES 2014-2023 ($ MILLION)
4.    GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES 2014-2023 ($ MILLION)
5.    GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES  2014-2023 ($ MILLION)
6.    GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES 2014-2023 ($ MILLION)
7.    GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES 2014-2023 ($ MILLION)
8.    GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES 2014-2023 ($ MILLION)
9.    GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES 2014-2023 ($ MILLION)
10.    GLOBAL VACCINES & VACCINATION MARKET BY TYPE 2014-2023 ($ MILLION)
11.    GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES 2014-2023 ($ MILLION)
12.    GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES 2014-2023 ($ MILLION)
13.    GLOBAL VACCINES & VACCINATION MARKET BY DISEASE INDICATION 2014-2023($MILLION
14.    GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES 2014-2023 ($ MILLION)
15.    GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA 2014-2023 ($ MILLION)
16.    GLOBAL VACCINES & VACCINATION MARKET BY MMR 2014-2023 ($ MILLION)
17.    GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA 2014-2023 ($ MILLION)
18.    GLOBAL VACCINES & VACCINATION MARKET BY DTP 2014-2023 ($ MILLION)
19.    GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS 2014-2023 ($ MILLION)
20.    GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS 2014-2023 ($ MILLION)
21.    GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA 2014-2023 ($ MILLION)
22.    GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL 2014-2023 ($ MILLION)
23.    GLOBAL VACCINES & VACCINATION MARKET BY POLIO 2014-2023 ($ MILLION)
24.    GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2023 ($ MILLION)
25.    GLOBAL VACCINES & VACCINATION MARKET BY CANCER 2014-2023 ($ MILLION)
26.    GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER 2014-2023 ($ MILLION)
27.    GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2023 ($ MILLION)
28.    GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES 2014-2023 ($ MILLION)
29.    GLOBAL VACCINES & VACCINATION MARKET BY END USERS 2014-2023($MILLION
30.    GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS 2014-2023 ($ MILLION)
31.    GLOBAL VACCINES & VACCINATION MARKET BY ADULTS 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1.    GLOBAL VACCINES & VACCINATION MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
2.    GLOBAL VACCINES & VACCINATION MARKET BY SUBUNIT VACCINES 2014-2023 ($ MILLION)
3.    GLOBAL VACCINES & VACCINATION MARKET BY LIVE ATTENUATED VACCINES 2014-2023 ($ MILLION)
4.    GLOBAL VACCINES & VACCINATION MARKET BY CONJUGATE VACCINES 2014-2023 ($ MILLION)
5.    GLOBAL VACCINES & VACCINATION MARKET BY INACTIVATED VACCINES 2014-2023 ($ MILLION)
6.    GLOBAL VACCINES & VACCINATION MARKET BY RECOMBINANT VECTOR VACCINES,2014-2023 ($ MILLION)
7.    GLOBAL VACCINES & VACCINATION MARKET BY TOXOID VACCINES 2014-2023 ($ MILLION)
8.    GLOBAL VACCINES & VACCINATION MARKET BY SYNTHETIC VACCINES 2014-2023 ($ MILLION)
9.    GLOBAL VACCINES & VACCINATION MARKET BY DENDRITIC CELL VACCINES 2014-2023 ($ MILLION)
10.    GLOBAL VACCINES & VACCINATION MARKET BY TYPE 2014-2023 ($ MILLION)
11.    GLOBAL VACCINES & VACCINATION MARKET BY PREVENTIVE VACCINES 2014-2023 ($ MILLION)
12.    GLOBAL VACCINES & VACCINATION MARKET BY THERAPEUTIC VACCINES 2014-2023 ($ MILLION)
13.    GLOBAL VACCINES & VACCINATION MARKET BY DISEASE INDICATION 2014-2023($MILLION
14.    GLOBAL VACCINES & VACCINATION MARKET BY INFECTIOUS DISEASES 2014-2023 ($ MILLION)
15.    GLOBAL VACCINES & VACCINATION MARKET BY PNEUMONIA 2014-2023 ($ MILLION)
16.    GLOBAL VACCINES & VACCINATION MARKET BY MMR 2014-2023 ($ MILLION)
17.    GLOBAL VACCINES & VACCINATION MARKET BY INFLUENZA 2014-2023 ($ MILLION)
18.    GLOBAL VACCINES & VACCINATION MARKET BY DTP 2014-2023 ($ MILLION)
19.    GLOBAL VACCINES & VACCINATION MARKET BY HEPATITIS 2014-2023 ($ MILLION)
20.    GLOBAL VACCINES & VACCINATION MARKET BY ROTAVIRUS 2014-2023 ($ MILLION)
21.    GLOBAL VACCINES & VACCINATION MARKET BY VARICELLA  2014-2023 ($ MILLION)
22.    GLOBAL VACCINES & VACCINATION MARKET BY MENINGOCOCCAL 2014-2023 ($ MILLION)
23.    GLOBAL VACCINES & VACCINATION MARKET BY POLIO 2014-2023 ($ MILLION)
24.    GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2023 ($ MILLION)
25.    GLOBAL VACCINES & VACCINATION MARKET BY CANCER 2014-2023 ($ MILLION)
26.    GLOBAL VACCINES & VACCINATION MARKET BY CERVICAL CANCER 2014-2023 ($ MILLION)
27.    GLOBAL VACCINES & VACCINATION MARKET BY OTHERS 2014-2023 ($ MILLION)
28.    GLOBAL VACCINES & VACCINATION MARKET BY ALLERGIES 2014-2023 ($ MILLION)
29.    GLOBAL VACCINES & VACCINATION MARKET BY END USERS 2014-2023($MILLION
30.    GLOBAL VACCINES & VACCINATION MARKET BY PEDIATRICS 2014-2023 ($ MILLION)
31.    GLOBAL VACCINES & VACCINATION MARKET BY ADULTS 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

UPCOMING REPORTS

No upcoming reports available under this subcategory.

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion